These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
200 related articles for article (PubMed ID: 36266286)
41. p53 gene mutants expression, cellular proliferation and differentiation in oesophageal carcinoma and non-cancerous epithelium. Jaskiewicz K; De Groot KM Anticancer Res; 1994; 14(1A):137-40. PubMed ID: 8166440 [TBL] [Abstract][Full Text] [Related]
42. Effects of TP53 mutational status on gene expression patterns across 10 human cancer types. Parikh N; Hilsenbeck S; Creighton CJ; Dayaram T; Shuck R; Shinbrot E; Xi L; Gibbs RA; Wheeler DA; Donehower LA J Pathol; 2014 Apr; 232(5):522-33. PubMed ID: 24374933 [TBL] [Abstract][Full Text] [Related]
43. P73 expression in basal layers of head and neck squamous epithelium: a role in differentiation and carcinogenesis in concert with p53 and p63? Faridoni-Laurens L; Bosq J; Janot F; Vayssade M; Le Bihan ML; Kaghad M; Caput D; Bénard J; Ahomadegbe JC Oncogene; 2001 Aug; 20(38):5302-12. PubMed ID: 11536043 [TBL] [Abstract][Full Text] [Related]
44. Antigen-specific immunity does not mediate acute regression of UVB-induced p53-mutant clones. Remenyik E; Wikonkál NM; Zhang W; Paliwal V; Brash DE Oncogene; 2003 Sep; 22(41):6369-76. PubMed ID: 14508517 [TBL] [Abstract][Full Text] [Related]
45. Requirement of wild-type p53 protein for maintenance of chromosomal integrity. Honma M; Momose M; Tanabe H; Sakamoto H; Yu Y; Little JB; Sofuni T; Hayashi M Mol Carcinog; 2000 Aug; 28(4):203-14. PubMed ID: 10972990 [TBL] [Abstract][Full Text] [Related]
46. Increasing genomic instability during premalignant neoplastic progression revealed through high resolution array-CGH. Lai LA; Paulson TG; Li X; Sanchez CA; Maley C; Odze RD; Reid BJ; Rabinovitch PS Genes Chromosomes Cancer; 2007 Jun; 46(6):532-42. PubMed ID: 17330261 [TBL] [Abstract][Full Text] [Related]
47. p53 expression in squamous dysplasia associated with carcinoma of the oesophagus: evidence for field carcinogenesis. Yasuda M; Kuwano H; Watanabe M; Toh Y; Ohno S; Sugimachi K Br J Cancer; 2000 Oct; 83(8):1033-8. PubMed ID: 10993651 [TBL] [Abstract][Full Text] [Related]
48. Increased oncogenicity of subclones of SV40 large T-induced neuroectodermal tumor cell lines after loss of large T expression and concomitant mutation in p53. Salewski H; Bayer TA; Eidhoff U; Preuss U; Weggen S; Scheidtmann KH Cancer Res; 1999 Apr; 59(8):1980-6. PubMed ID: 10213510 [TBL] [Abstract][Full Text] [Related]
50. Inhibition of glucosylceramide synthase eliminates the oncogenic function of p53 R273H mutant in the epithelial-mesenchymal transition and induced pluripotency of colon cancer cells. Hosain SB; Khiste SK; Uddin MB; Vorubindi V; Ingram C; Zhang S; Hill RA; Gu X; Liu YY Oncotarget; 2016 Sep; 7(37):60575-60592. PubMed ID: 27517620 [TBL] [Abstract][Full Text] [Related]
51. Differentiated vulvar intraepithelial neoplasia contains Tp53 mutations and is genetically linked to vulvar squamous cell carcinoma. Pinto AP; Miron A; Yassin Y; Monte N; Woo TY; Mehra KK; Medeiros F; Crum CP Mod Pathol; 2010 Mar; 23(3):404-12. PubMed ID: 20062014 [TBL] [Abstract][Full Text] [Related]
52. Cell competition: winning out by losing notch. Alcolea MP; Jones PH Cell Cycle; 2015; 14(1):9-17. PubMed ID: 25551772 [TBL] [Abstract][Full Text] [Related]
53. p53 and its mutants on the slippery road from stemness to carcinogenesis. Molchadsky A; Rotter V Carcinogenesis; 2017 Apr; 38(4):347-358. PubMed ID: 28334334 [TBL] [Abstract][Full Text] [Related]
54. Modeling the Etiology of p53-mutated Cancer Cells. Perez RE; Shen H; Duan L; Kim RH; Kim T; Park NH; Maki CG J Biol Chem; 2016 May; 291(19):10131-47. PubMed ID: 27022024 [TBL] [Abstract][Full Text] [Related]
55. The MutSβ complex is a modulator of p53-driven tumorigenesis through its functions in both DNA double-strand break repair and mismatch repair. van Oers JM; Edwards Y; Chahwan R; Zhang W; Smith C; Pechuan X; Schaetzlein S; Jin B; Wang Y; Bergman A; Scharff MD; Edelmann W Oncogene; 2014 Jul; 33(30):3939-46. PubMed ID: 24013230 [TBL] [Abstract][Full Text] [Related]
56. 3-Methylcholanthrene triggers the differentiation of alveolar tumor cells from canine bronchial basal cells and an altered p53 gene promotes their clonal expansion. TenHave-Opbroek AA; Shi XB; Gumerlock PH Carcinogenesis; 2000 Aug; 21(8):1477-84. PubMed ID: 10910947 [TBL] [Abstract][Full Text] [Related]
57. Genetic pathways of two types of gastric cancer. Tahara E IARC Sci Publ; 2004; (157):327-49. PubMed ID: 15055305 [TBL] [Abstract][Full Text] [Related]
58. Association of allelic imbalance at locus D13S171 (BRCA2) and p53 alterations with tumor kinetics and chromosomal instability (aneuploidy) in nonsmall cell lung carcinoma. Gorgoulis VG; Kotsinas A; Zacharatos P; Mariatos G; Liloglou T; Tsoli E; Kokotas S; Fassoulas C; Field JK; Kittas C Cancer; 2000 Nov; 89(9):1933-45. PubMed ID: 11064350 [TBL] [Abstract][Full Text] [Related]